Clinical Trial Update: Direct to Patient Minimal Risk Biospecimen and Data Collection Research

View source ↗

Summary

A direct-to-patient, minimal-risk biospecimen and data collection study sponsored by Joined Bio, currently NOT_YET_RECRUITING, enrolling both healthy individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease
• Chronic Kidney Disease
• Systemic Lupus Erythematosus

Snippet

Sponsor: Joined Bio | Conditions: Healthy, Lupus | Status: NOT_YET_RECRUITING